
NYSE:INGR
This summary was created by AI, based on 1 opinions in the last 12 months.
Ingredion Incorporated (INGR-N) has seen a downturn of 10% this year, influenced by a less-than-stellar quarterly performance indicated by results reported in early May. Despite this setback, the recent acquisition of Tate & Lyle is poised to significantly enhance Ingredion's position in the competitive ingredients market, potentially transforming it into a leading powerhouse. Experts recognize the strategic benefits that this acquisition brings, suggesting that it could lead to improved long-term growth and profitability. However, analysts remain cautious in the short term, considering the recent quarterly performance as a factor that investors need to watch closely. The market's response will largely depend on how effectively Ingredion integrates the new acquisition and navigates current challenges.
Ingredion Incorporated is a American stock, trading under the symbol INGR (previously INGR-N on Stockchase) on the New York Stock Exchange (INGR). It is usually referred to as NYSE:INGR or INGR
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on INGR (previously INGR-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Ingredion Incorporated.
Ingredion Incorporated was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Ingredion Incorporated.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Ingredion Incorporated.
Ingredion Incorporated is covered by Stockchase experts and is worth watching.
On 2026-09-03, Ingredion Incorporated (INGR) stock closed at a price of $101.68.
Is down 10% this year, partially due to an imperfect quarter in early May. They bought Tate & Lyle which would make them a powerhouse in the ingredients space.